Axovant Announces Expansion of Dementia Drug Development Pipeline and Reports Financial Results for the Second Fiscal Quarter and Six Months Ended September 30, 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Axovant Announces Expansion of Dementia Drug Development Pipeline and Reports Financial Results for the Second Fiscal Quarter and Six Months Ended September 30, 2015

Axovant Sciences Ltd. (AXON) Tops Q2 EPS by 12c

November 2, 2015 4:38 PM EST

Axovant Sciences Ltd. (NYSE: AXON) reported Q2 EPS of ($0.12), $0.12 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Axovant Sciences Ltd. (AXON) click here.

... More